Biotech company Cereno Scientific has now published its report for the first quarter of the year. CEO Sten R Sörensen visited BioStock's studio to summarize 2022 so far, talk more about the broadening of the company's pipeline, and provide an update on the Phase II study with CS1.
Watch the interview with Cereno Scientifics CEO below.